The largest database of trusted experimental protocols

56 protocols using autoflex 2

1

Oxidation and Reduction Analysis of His-Sll1961

Check if the same lab product or an alternative is used in the 5 most similar protocols
25 μg of His-Sll1961 protein was oxidized with 1 mM diamide for 60 min or reduced with 20 mM DTT for 15 min at room temperature. After desalting using Zeba Spin Desalting Column (Thermo Fisher, Waltham, USA) and protein quantification using Bio-Rad Protein Assay Kit, samples were subjected to digestion by Sequencing Grade Modified Trypsin (Promega, Fitchburg, USA) at a ratio of 20:1 (w/w) for 2 h at 37 °C. After desalting with ZipTip (Millipore), 1 μl of the sample was mixed with 4 μl of matrix solution of α-cyano-4-hydroxy cinnamic acid and spotted on the sample plate. MALDI-TOF mass spectra were acquired with Autoflex II (Bruker, Bremen, Germany). Calibration was performed using a Peptide Calibration Standard (Bruker) spotted on the target position next to the sample.
+ Open protocol
+ Expand
2

Macrocyclic Peptide Synthesis via SPPS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrocyclic peptides were synthesized by standard Fmoc solid-phase peptide synthesis (SPPS) using a Syro Wave automated peptide synthesizer (Biotage). The resulting peptide–resin (25 μmol scale) was treated with a solution of 92.5% trifluoroacetic acid (TFA), 2.5% water, 2.5% triisopropylsilane and 2.5% ethanedithiol, to yield the free linear N-CIAc-peptide. Following diethyl ether precipitation, the pellet was dissolved in 10 ml triethylamine containing DMSO and incubated for 1 h at 25 °C, to yield the corresponding macrocycle. The peptide suspensions were then acidified by addition of TFA to quench the macrocyclization reaction. The macrocycle was purified by RP-HPLC, using a Prominence HPLC system (Shimadzu) under linear gradient conditions. Mobile phase A (comprising water with 0.1% TFA) was mixed with mobile phase B (0.1% TFA in acetonitrile). Purified peptides were lyophilized in vacuo and molecular mass was confirmed by MALDI MS, using an AutoFlex II instrument (Bruker Daltonics).
+ Open protocol
+ Expand
3

Macrocyclic Peptide Synthesis and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrocycles were synthesized by standard Fmoc solid-phase peptide synthesis (SPPS) using a Syro Wave automated peptide synthesizer (Biotage). The resulting peptide–resin (25 μmol scale) was treated with a solution of 92.5% trifluoroacetic acid (TFA), 2.5% water, 2.5% triisopropylsilane and 2.5% ethanedithiol, to yield the free linear N-ClAc-peptide. Following diethyl ether precipitation, the pellet was dissolved in 10 ml triethylamine containing DMSO and incubated for 1 h at 25 °C, to yield the corresponding macrocycle. The peptide suspensions were then acidified by addition of TFA to quench the macrocyclization reaction. The macrocycle was purified by reversed-phase HPLC (RP-HPLC), using a Prominence HPLC system (Shimadzu) under linear gradient conditions. Mobile phase A (comprising water with 0.1% TFA) was mixed with mobile phase B (0.1% TFA in acetonitrile). Purified peptides were lyophilized in vacuo and molecular mass was confirmed by matrix-assisted laser desorption/ionization time-of-flight MS, using an AutoFlex II instrument (Bruker Daltonics).
+ Open protocol
+ Expand
4

MALDI-TOF-MS Analysis of Plasma Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three plasma samples (Exp_ivt, Cont_ivt, and Cont_Lys_ivt) were analyzed by MALDI-TOF-MS (Autoflex III, Bruker Daltonics, Yokohama, Japan). The "Eluate" fraction obtained by IP of the "high" fraction of Exp_ivt was also analyzed by MALDI-TOF-MS (Autoflex II, Bruker Daltonics). Each sample was diluted 75-fold with a 0.1% solution of trifluoroacetic acid. In preparing the matrix solution, 20 mg of sinapinic acid was dissolved in 50 µ l of TA solution (one volume of acetonitrile and two volumes of 0.1% solution of trifluoroacetic acid) according to the manufacturer's protocol. One volume of the diluted sample was mixed with two volumes of matrix, and 1 µ l of the mixed solution was spotted on the target plate. The spectra were acquired by irradiating the plasma sample and IP sample with a laser, with integration of a positive linear mode in one spectrum. The range of detection was from m/z 2,000 to 90,000. Double-digit m/z acquisitions by MALDI-TOF-MS analysis were ignored; because an error of 500 ppm from the true value was accepted during calibration.
+ Open protocol
+ Expand
5

Functionalized Hydrogel Precursors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thiolated hyaluronan (Glycosil) and polyethylene glycol diacrylate (PEGDA) MW3400 (Extralink) were purchased from BioTime Inc. Protease-cleavable peptide, KGGGPQGIWGQGK, with N-terminal acetylation (GenScript USA Inc.) was reacted with acrylate-PEG-SVA, MW3400 (Laysan Bio Inc, ACRL-PEG-SVA-3400) at a molar ratio of 1:2.5 in HEPBS buffer (20 mM HEPBS, 100 mM NaCl, 2 mM MgCl2, pH 8.0). The reaction was allowed to proceed overnight at 4°C with shaking and protected from light. The reaction solution then was dialyzed in 3500-Da MWCO dialysis membrane (Spectrum Laboratories Inc, 08-670-14A) against ultrapure water for 2 days, filter sterilized, frozen at −80°C, and lyophilized for 48 hours. Integrin-binding peptide GRGDS with C-terminal amidation (GenScript USA Inc.) was reacted with acrylate-PEG-SVA at a molar ratio of 1.2:1 GRGDS to PEG-SVA using the same protocol. PEGylation was verified by MALDI-TOF (Bruker AutoFlex II). The lyophilized powder was stored at −20°C and allowed to come to room temperature before use. Acrylate-functionalized peptides were protected from room light during all of the above steps.
+ Open protocol
+ Expand
6

Peptide Stability in Human Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptides were incubated at 37°C in 250 μl of human serum (Sigma Aldrich) for different periods of time. Samples were collected and peptide degradation stopped by freezing. Peptides were extracted from samples using the Proteo Miner Protein Enrichment System (Bio-Rad). Percentage of intact peptide was estimated by mass spectrometry (MS) using MALDI-TOFF as described previously[19 (link)] (Bruker Autoflex II) following their protocol. Measurements were performed in triplicate. MS data were analysed using the software Cliprot tools, Felx analysis, Bruker.
+ Open protocol
+ Expand
7

Synthetic Intermediate Purity Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The purity of each synthetic intermediate and the final DILP2 was assessed by analytical RP-HPLC and MALDI-TOF mass spectrometry using a Bruker Autoflex II instrument (Bremen, Germany) in the linear mode at 19.5 kV. Peptides were also quantitated by amino acid analysis of a 24 hour vapour phase acid hydrolyzate followed by derivatization with AccuTag chemistry and resolution of the labelled residues using a Shimadzu microbore RP-HPLC system (Melbourne, Australia).
+ Open protocol
+ Expand
8

Identification of Fucoxanthinol-Binding Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
HT-29 cells were lysed with NP-40 lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% NP-40, 1 mM DTT, and 0.5 mM PMSF) on ice for 30 min and centrifuged at 20,400 × g for 10 min at 4 °C. The supernatants were used as the whole-cell extracts of HT-29 cells. The extracts were incubated with empty or fucoxanthinol-fixed beads at 4 °C for 4 h. The beads were then washed three times with binding buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.1% NP-40). The proteins binding to the beads were eluted with Laemmli SDS sample buffer, subjected to 12% SDS-PAGE, and detected by silver staining. Each gel slice containing a fucoxanthinol-binding protein was subjected to in-gel digestion with Sequencing Grade Modified Trypsin (Promega, Madison, WI, USA). The resulting peptides were analyzed by Autoflex II (Bruker Daltonics, Billerica, MA, USA), and proteins were identified by peptide mass fingerprinting.
The recombinant His-tagged uS7 protein (His-uS7, ab137146, Abcam) was incubated with empty or fucoxanthinol-fixed beads at 4 °C for 4 h. The beads were then washed three times with binding buffer. His-uS7 binding to the beads was eluted with Laemmli SDS sample buffer, subjected to 12% SDS-PAGE, and detected by western blotting.
+ Open protocol
+ Expand
9

MALDI-TOF MS Protocol for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All MALDI-TOF mass spectra were acquired on a Bruker Autoflex II time-of-flight mass spectrometer (Bruker, Bremen, Germany) equipped with a delayed ion-extraction device and a 337-nm pulsed nitrogen laser. All measurements were carried out in reflected positive-ion mode with delayed ion extraction. The delay time for ion extraction and the extraction voltage were set at 90 ns and 20 kV, respectively. Each MS spectrum was acquired by the accumulation of 100 laser shots.
+ Open protocol
+ Expand
10

Purification and Analysis of Biomolecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemical reagents and solvents were obtained from commercial suppliers (Wako Pure Chemical Industries Co. Ltd, Nacalai Tesque Co., Ltd, Watanabe Chemical Industries Co. Ltd, Thermo Fisher Scientific K.K., and GE Healthcare) and used without further purification. DNA purification was accomplished using a GENE PREP STAR PI-80X DNA isolation system (KURABO). SDS-PAGE and Western blotting were performed using Mini-Protean III (Bio-Rad Laboratories, Inc.), Trans-Blot Turbo (Bio-Rad Laboratories, Inc.), and iBind Flex (Thermo Fisher Scientific) devices. Chemiluminescent images were detected using the Amersham Imager 680 detector (GE Healthcare). Reverse-phase HPLC was performed on a PU-4180 plus equipped with UV-4075 and MD-4010 detectors (JASCO). The absorbance at 220 nm and 488 nm was monitored by an MD-4010 photodiode array detector (PDA). MALDI-TOF MS analysis was performed on an Autoflex II (Bruker Daltonics Inc.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!